Similasan Nasen-Wundsalbe, Nasencreme

7680549600270 CH-54960 Nasencreme
Similasan Nasen-Wundsalbe, Nasencreme
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
2 x 5
Selling units
2
Measure
g
Galenic form
Nasencreme
Galenic group
Unknown

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
12/02/2024
Patient information leaflet
Français
12/02/2024
Patient information leaflet
Italien
12/02/2024

Detailed composition

Substance Quantity Type Category
acidum arsenicosum (HAB)
25.0 MG Substance Wirkstoff (Principe actif)
acidum nitricum (HAB)
25.0 MG Substance Wirkstoff (Principe actif)
graphites (HAB)
25.0 MG Substance Wirkstoff (Principe actif)
kalium bichromicum (HAB)
25.0 MG Substance Wirkstoff (Principe actif)
arachidis oleum hydrogenatum
200.0 MG Substance HBESI
alcohol cetylicus
100.0 MG Substance HBESI
polysorbatum 60
50.0 MG Substance HBESI
propylenglycolum
200.0 MG Substance HBESI
natrii chloroargentas
- Substance Konservierungsstoff (Conservateur)
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Similasan AG

8916 Jonen

Authorization information

Swissmedic authorization number
54960
Drug name
Similasan Nasen-Wundsalbe, Nasencreme
Galenic form
NASC
Authorization status
Z
Dispensing category
D
First authorization
04/01/2001
Authorization expiration date
31/12/9999
IT Number
20.01.1.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild bei trockener und gereizter Nasenschleimhaut

Package details

Description (FR)
SIMILASAN Pommade nasale vulnéraire 2 tb 5 g
Description (DE)
SIMILASAN Nasen-Wundsalbe 2 Tb 5 g
Market launch
04/01/2001
Narcotic (BTM)
No

Other package sizes (1)

None
None None
GTIN: None
Not in V1
Buy us a coffee Explore the data